Cargando…
Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application
BACKGROUND: Overall, 55% of the German population suffers from primary episodic headaches according to recent studies. Inadequate management of headache disorders is a significant medical problem. The prevalence of medication overuse headache (MOH) is about 1% with an estimated number of 800,000 peo...
Autores principales: | Diener, Hans-Christoph, Donoghue, Stephen, Gaul, Charly, Holle-Lee, Dagny, Jöckel, Karl-Heinz, Mian, Alec, Schröder, Bernadette, Kühl, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092034/ https://www.ncbi.nlm.nih.gov/pubmed/35546412 http://dx.doi.org/10.1186/s13063-022-06329-2 |
Ejemplares similares
-
Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022) -
Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache
por: Gaul, Charly, et al.
Publicado: (2011) -
Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
por: Limberg, Nicole
Publicado: (2023) -
Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review
por: Kaltseis, Katharina, et al.
Publicado: (2022) -
Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)